“The American public is highly aware that obesity is medically treatable and that reducing it will also save people from a ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...

Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...

A major new study has found that a drug called semaglutide can greatly improve heart health in people who are overweight or ...

Doctronic reports that while Ozempic and similar GLP-1s aren’t physically addictive, psychological dependence may occur.

Researchers found benefits including reduced blood pressure were reversed after patients ceased taking the jab ...

Jaime Bautch and Mykala Lopez from Bellissimo Aesthetics join us on The Morning Blend to discuss treatments that pair with ...